ARIPIPRAZOLE-AU aripiprazole 5 mg tablet bottle

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

aripiprazole, Quantity: 5 mg

Verfügbar ab:

Medis Pharma Pty Ltd

INN (Internationale Bezeichnung):

aripiprazole

Darreichungsform:

Tablet, uncoated

Zusammensetzung:

Excipient Ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; maize starch; hyprolose

Verabreichungsweg:

Oral

Einheiten im Paket:

100, 250

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

Aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,Acute treatment of manic or mixed episodes associated with Bipolar I Disorder in adults as monotherapy and in combination with lithium or valproate;,Maintenance treatment of manic or mixed episodes in Bipolar I Disorder in adults as monotherapy.

Produktbesonderheiten:

Visual Identification: 5 mm, round, biconvex, white uncoated tablets with 5 debossed on one side and ZL on the other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2014-10-29